Patients also have the opportunity to participate in clinical research trials from multiple collaborative groups through the Ochsner Community Clinical Oncology Program (CCOP). Ochsner has been actively involved in cancer research since its inception and is currently the largest clinical research program in Oncology in the New Orleans region. The program currently provides access to our trials at our Jefferson Highway, Baton Rouge, Covington and Baptist sites with plans to expand into our other locations in the future. By having numerous locations involved in research, Ochsner provides access to clinical trials for patients living in southern Louisiana and parts of Mississippi, with plans underway to geographically increase access.
The Ochsner CCOP has been continuously funded by the National Cancer Institute (NCI) since 1983 and remains the core of the program. The CCOP provides a direct link to the NCI and participation in clinical trials for the following research bases: the Eastern Cooperative Oncology Group (ECOG); the National Surgical Adjuvant Breast and Bowel Project (NSABP); the Radiation therapy Oncology Group (RTOG); the North Central Cancer Treatment Group(NCCTG); and the Children’s Oncology Group (COG).
Evaluation of new treatments and technologies also occurs in collaboration with industry and other national research consortia providing access to cutting edge treatments that are being investigated. The Ochsner Cancer Institute facilitates active involvement of the physicians most responsible for treating cancer patients across the multidisciplinary programs by providing them with important access to research infrastructure
Clinical Trials and Research
A clinical trial is the study of a medical treatment in human volunteers. The treatment may be a new drug or a new use for an older drug. The treatment could also be a new device or a new surgical technique.
Clinical trials are an excellent way for people to help doctors find ways to improve cancer care. Patients who volunteer to participate in a clinical trial have known health problems. They decide to participate in research to help doctors better understand, diagnose, treat, or cure that disease or condition. The information gained through these studies about investigational treatments may help not only the patient but many other people living with the condition as well.
Clinical trials are important because they compare new treatments with accepted treatments. They allow researchers to find out whether a new treatment works better than accepted treatments. The new treatment might work as well or better than standard therapies, and the new treatment might have fewer or milder side effects. On the other hand, the new treatment might not work as well or might cause more side effects than standard treatments.
Clinical trials help pharmaceutical and biotechnology companies develop medicines and devices that are safer and more effective with fewer side effects. Clinical trials also help these companies decide whether it is worthwhile to seek approval from the U.S. Food and Drug Administration for a new treatment.
Clinical trials are also important in finding therapies when no standard treatment exists. Clinical trials help show how well the new treatment works and what side effects it may cause.
To view a current listing of clinicial trials taking place at Ochsner, click here.
Type of cancer-related clinical trials that take place at Ochsner include:
- Brain cancer
- Head and neck cancers
- Breast cancer
- Colon, colorectal, and rectal cancer
- Biliary tract cancers
- Pancreatic cancer
- Neuroendocrine tumors
- Esophageal cancer
- Lung cancer
- Prostate cancer
- Gynecologic cancers